187 related articles for article (PubMed ID: 32967970)
21. p53 down-regulates phosphatase and tensin homologue deleted on chromosome 10 protein stability partially through caspase-mediated degradation in cells with proteasome dysfunction.
Tang Y; Eng C
Cancer Res; 2006 Jun; 66(12):6139-48. PubMed ID: 16778187
[TBL] [Abstract][Full Text] [Related]
22. A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers.
Denlinger CS; Meropol NJ; Li T; Lewis NL; Engstrom PF; Weiner LM; Cheng JD; Alpaugh RK; Cooper H; Wright JJ; Cohen SJ
Clin Colorectal Cancer; 2014 Jun; 13(2):81-6. PubMed ID: 24512954
[TBL] [Abstract][Full Text] [Related]
23. Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.
Vaeteewoottacharn K; Pairojkul C; Kariya R; Muisuk K; Imtawil K; Chamgramol Y; Bhudhisawasdi V; Khuntikeo N; Pugkhem A; Saeseow OT; Silsirivanit A; Wongkham C; Wongkham S; Okada S
Cells; 2019 May; 8(5):. PubMed ID: 31126020
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
Meng F; DeMorrow S; Venter J; Frampton G; Han Y; Francis H; Standeford H; Avila S; McDaniel K; McMillin M; Afroze S; Guerrier M; Quezada M; Ray D; Kennedy L; Hargrove L; Glaser S; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G759-68. PubMed ID: 24603459
[TBL] [Abstract][Full Text] [Related]
25. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.
Wang LJ; He CC; Sui X; Cai MJ; Zhou CY; Ma JL; Wu L; Wang H; Han SX; Zhu Q
Oncotarget; 2015 Mar; 6(8):5932-46. PubMed ID: 25803229
[TBL] [Abstract][Full Text] [Related]
26. PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma.
Liu CZ; Liu W; Zheng Y; Su JM; Li JJ; Yu L; He XD; Chen SS
Chin Med Sci J; 2012 Jun; 27(2):65-72. PubMed ID: 22770403
[TBL] [Abstract][Full Text] [Related]
27. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways.
Prakobwong S; Gupta SC; Kim JH; Sung B; Pinlaor P; Hiraku Y; Wongkham S; Sripa B; Pinlaor S; Aggarwal BB
Carcinogenesis; 2011 Sep; 32(9):1372-80. PubMed ID: 21325634
[TBL] [Abstract][Full Text] [Related]
28. Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells.
Ustundag Y; Bronk SF; Gores GJ
World J Gastroenterol; 2007 Feb; 13(6):851-7. PubMed ID: 17352013
[TBL] [Abstract][Full Text] [Related]
29. Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice.
Xu X; Kobayashi S; Qiao W; Li C; Xiao C; Radaeva S; Stiles B; Wang RH; Ohara N; Yoshino T; LeRoith D; Torbenson MS; Gores GJ; Wu H; Gao B; Deng CX
J Clin Invest; 2006 Jul; 116(7):1843-52. PubMed ID: 16767220
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of cholangiocarcinoma growth by tannic acid.
Marienfeld C; Tadlock L; Yamagiwa Y; Patel T
Hepatology; 2003 May; 37(5):1097-104. PubMed ID: 12717390
[TBL] [Abstract][Full Text] [Related]
31. miR-181b-5p Promotes the Progression of Cholangiocarcinoma by Targeting PARK2 via PTEN/PI3K/AKT Signaling Pathway.
Jiang ZL; Zhang FX; Zhan HL; Yang HJ; Zhang SY; Liu ZH; Jiang Y; Lv LZ; Ke RS
Biochem Genet; 2022 Feb; 60(1):223-240. PubMed ID: 34169384
[TBL] [Abstract][Full Text] [Related]
32. GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.
Chen WT; Zhu G; Pfaffenbach K; Kanel G; Stiles B; Lee AS
Oncogene; 2014 Oct; 33(42):4997-5005. PubMed ID: 24141775
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of ubiquitin proteasome function prevents monocrotaline-induced pulmonary arterial remodeling.
Zhu Y; Wu Y; Shi W; Wang J; Yan X; Wang Q; Liu Y; Yang L; Gao L; Li M
Life Sci; 2017 Mar; 173():36-42. PubMed ID: 28212825
[TBL] [Abstract][Full Text] [Related]
34. Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction.
Winter JM; Fresenius HL; Cunningham CN; Wei P; Keys HR; Berg J; Bott A; Yadav T; Ryan J; Sirohi D; Tripp SR; Barta P; Agarwal N; Letai A; Sabatini DM; Wohlever ML; Rutter J
Elife; 2022 Nov; 11():. PubMed ID: 36409067
[TBL] [Abstract][Full Text] [Related]
35. Benefits of Metformin Use for Cholangiocarcinoma.
Kaewpitoon SJ; Loyd RA; Rujirakul R; Panpimanmas S; Matrakool L; Tongtawee T; Kootanavanichpong N; Kompor P; Chavengkun W; Kujapun J; Norkaew J; Ponphimai S; Padchasuwan N; Pholsripradit P; Eksanti T; Phatisena T; Kaewpitoon N
Asian Pac J Cancer Prev; 2015; 16(18):8079-83. PubMed ID: 26745042
[TBL] [Abstract][Full Text] [Related]
36. MDM2 regulates hypoxic hypoxia-inducible factor 1α stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner.
Joshi S; Singh AR; Durden DL
J Biol Chem; 2014 Aug; 289(33):22785-22797. PubMed ID: 24982421
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1.
Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
Aging (Albany NY); 2021 Sep; 13(17):21325-21344. PubMed ID: 34499615
[TBL] [Abstract][Full Text] [Related]
38. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.
Seubwai W; Wongkham C; Puapairoj A; Okada S; Wongkham S
Cancer; 2010 Dec; 116(23):5535-43. PubMed ID: 20681031
[TBL] [Abstract][Full Text] [Related]
39. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling.
Wang Y; Liang Y; Yang G; Lan Y; Han J; Wang J; Yin D; Song R; Zheng T; Zhang S; Pan S; Liu X; Zhu M; Liu Y; Cui Y; Meng F; Zhang B; Liang S; Guo H; Liu Y; Hassan MK; Liu L
J Exp Clin Cancer Res; 2018 Dec; 37(1):300. PubMed ID: 30514341
[TBL] [Abstract][Full Text] [Related]
40. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target.
Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S
Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]